The North America fluoroscopy market was valued at USD 2.20 Billion in 2024, driven by the continuous technological advancements in the fluoroscopy technology. The market is anticipated to grow at a CAGR of 4.70% during the forecast period of 2025-2034, with the values likely to reach USD 3.48 Billion by 2034.
Koninklijke Philips N.V.
Koninklijke Philips N.V., founded in 1891 and headquartered in Amsterdam, Netherlands, is a prominent global health technology company. Philips offers advanced fluoroscopy systems, including the Azurion platform, which provides high-definition imaging and enhanced patient safety features for a wide range of diagnostic and interventional procedures in North America.
Other key players in the market include Shimadzu Corporation, Hologic, Inc., Agfa Healthcare, Hitachi Medical Systems, Carestream Health Inc., and Ziehm Imaging.
This product will be delivered within 3-5 business days.
North America Fluoroscopy Market Overview
Fluoroscopy is an imaging technique that uses X-rays to obtain real-time moving images of the inside of the body. It is commonly used in diagnostic and interventional procedures, such as catheter placements, gastrointestinal studies, and joint injections, providing continuous imaging to guide medical professionals during treatments.North America Fluoroscopy Market Growth Drivers
Innovations in Fluoroscopy Drive Growth in the Market
The increased demand for advanced imaging technologies, along with the growing focus on improving patient care are key drivers of the market. For instance, in November 2024, Detection Technology, a leader in X-ray detector solutions, introduced an enhanced portfolio of flat panel X-ray detectors at RSNA 2024. This range includes 20 new products offering high frame rates, excellent image quality at low doses, and a wide dynamic range, tailored for medical applications like fluoroscopy. This innovation will likely drive market growth by improving the efficiency and accuracy of diagnostic procedures, especially in image-guided surgery and fluoroscopy, during the forecast period.Advent of Mobile Fluoroscopy Systems to Meet Rising North America Fluoroscopy Market Demand
Key factors such as the need for portable, high-quality imaging in surgical settings are propelling the fluoroscopy market in North America. For instance, in November 2021, Fujifilm Healthcare Americas launched the Persona CS, a mobile fluoroscopy system designed for live imaging during surgeries. With its advanced onboard X-ray generator and high-quality cesium iodide flat-panel detectors, this system improves imaging for patients of all sizes. Its portability and performance are expected to boost the adoption of mobile fluoroscopy systems, positively impacting market growth over the forecast period.North America Fluoroscopy Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
FDA Clearances Driving Innovation and Growth in Fluoroscopy Technologies
The market is witnessing growth due to increased FDA clearances for advanced imaging systems, improving diagnostic accuracy, and expanding the adoption of fluoroscopy in clinical and surgical applications. For instance, in November 2024, Augmedics received FDA 510(k) clearance for a new registration method for its xvision Spine System®. The CT-to-fluoroscopy (CT-Fluoro) method enables navigation using preoperative CT scans and 2D fluoroscopic images, removing the need for 3D intraoperative imaging.Increasing Demand for Minimally Invasive Procedures Boosts Fluoroscopy Market Demand
The growing preference for minimally invasive procedures in North America is boosting the demand for fluoroscopy systems. For instance, in March 2024, GE HealthCare showcased its latest image-guiding solutions, including surgery, ultrasound, and CT-navigation technologies, at the Society of Interventional Radiology Annual Meeting. The increased adoption of minimally invasive solutions is expected to continue driving the demand for fluoroscopy systems, contributing to market development in the region.Growing Prevalence of Chronic Diseases to Enhance Fluoroscopy Market Value
The increasing prevalence of chronic diseases such as cardiovascular conditions, cancer, and musculoskeletal disorders is driving the demand for fluoroscopy systems in North America. For instance, it is estimated by the National Cancer Institute that nearly 2,002,140 new cancer cases are likely to be diagnosed in the United States with 611,720 deaths associated with the condition. These diseases often require advanced imaging for diagnosis and treatment monitoring. As the incidence of chronic diseases rises, the need for reliable, real-time imaging solutions like fluoroscopy is expected to accelerate, further expanding the market.Increased Adoption of Point-of-Care Fluoroscopy Drives Market Growth
The growing adoption of point-of-care fluoroscopy systems in North America is a key trend boosting market growth. These portable, user-friendly devices allow for real-time imaging in various clinical settings, such as emergency rooms and outpatient facilities. As healthcare providers seek more efficient diagnostic tools, the demand for point-of-care fluoroscopy systems is expected to drive substantial market growth in the coming years.North America Fluoroscopy Market Segmentation
The report offers a detailed analysis of the market based on the following segments:Market Breakup by Component
- Fixed Fluoroscopes
- Mobile Fluoroscopes
- Full-size Fluoroscopes
- Mini Fluoroscopes
Market Breakup by Application
- Orthopedic
- Cardiovascular
- Neurology
- Gastrointestinal
- Urology
- General Surgery
- Others
Market Breakup by End User
- Hospital and Specialty Clinics
- Diagnostic and Imaging Centers
- Others
Market Breakup by Country
- United States of America
- Canada
North America Fluoroscopy Market Share
Based on application, the orthopedic segment is expected to lead the market due to the high demand for real-time imaging during joint surgeries, spinal procedures, and fracture management. As estimated by the publisher, the global fluoroscopy equipment market is anticipated to grow at a CAGR of 4.80% during the forecast period of 2025-2034. Fluoroscopy is crucial for the precise placement of screws, pins, and other hardware in orthopedic surgeries, enhancing surgical outcomes. As the aging population increases and the prevalence of musculoskeletal disorders rises, the demand for fluoroscopy in orthopedics is expected to continue driving the market in the forecast period.North America Fluoroscopy Market Analysis by Region
The United States leads the market due to its advanced healthcare infrastructure, high adoption of innovative imaging technologies, and significant investment in medical devices. It has a large number of healthcare facilities and a high demand for fluoroscopy in various medical procedures, including minimally invasive surgeries. Additionally, the country's strong regulatory support and reimbursement policies further drive market growth, making it the dominant player in the North American fluoroscopy market compared to Canada.Leading Players in the North America Fluoroscopy Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:Siemens Healthineers AG
Siemens Healthineers AG, founded in 1847 and headquartered in Erlangen, Germany, is a global leader in medical technology. Siemens offers advanced fluoroscopy systems, including the Artis range, known for their high-resolution imaging and real-time performance in both diagnostic and interventional procedures. For instance, in September 2021, Siemens Healthineers launched the Luminos Impulse, a fluoroscopy system featuring a new design and advanced capabilities typically found in high-end systems. These included a seamless imaging chain, comprehensive dose optimisation, cybersecurity features, and detector-sharing capabilities for radiography.GE Healthcare Technologies Inc.
GE Healthcare Technologies Inc., established in 1892 and based in Chicago, Illinois, is a leading healthcare technology company. In fluoroscopy, GE Healthcare provides innovative solutions such as the OEC series, known for delivering precise imaging and real-time guidance during minimally invasive procedures, supporting clinical decisions in various specialties. In March 2024, GE HealthCare showcased advanced imaging, surgery, ultrasound, and CT-navigation technologies at the 2024 Society of Interventional Radiology meeting.Koninklijke Philips N.V.
Koninklijke Philips N.V., founded in 1891 and headquartered in Amsterdam, Netherlands, is a prominent global health technology company. Philips offers advanced fluoroscopy systems, including the Azurion platform, which provides high-definition imaging and enhanced patient safety features for a wide range of diagnostic and interventional procedures in North America.
Canon Medical Systems Corporation
Canon Medical Systems Corporation, established in 1930 and headquartered in Otawara, Japan, is a leader in medical imaging solutions. Canon's fluoroscopy offerings, such as the Radrex series, provide high-quality imaging for a range of diagnostic and interventional procedures, focusing on real-time imaging and ease of use in clinical environments across North America.Other key players in the market include Shimadzu Corporation, Hologic, Inc., Agfa Healthcare, Hitachi Medical Systems, Carestream Health Inc., and Ziehm Imaging.
Key Questions Answered in the North America Fluoroscopy Market
- What was the North America fluoroscopy market value in 2024?
- What is the North America fluoroscopy market forecast outlook for 2025-2034?
- What is the market breakup based on the component?
- What is the market breakup based on the application?
- What is the market breakup based on the end user?
- What are the major factors aiding the North America fluoroscopy market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major North America fluoroscopy market trends?
- Which component will lead the market segment?
- Which application will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the North America fluoroscopy market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 North America Fluoroscopy Market Overview
4 Vendor Positioning Analysis
5 North America Fluoroscopy Market Landscape*
6 North America Fluoroscopy Market Dynamics
7 North America Fluoroscopy Market Segmentation (218-2034)
8 United States of America Fluoroscopy Market (218-2034)
9 Canada Fluoroscopy Market (218-2034)
10 Patent Analysis
11 Grants Analysis
12 Funding and Investment Analysis
13 Strategic Initiatives
14 Supplier Landscape
15 North America Fluoroscopy Market - Distribution Model (Additional Insight)
Companies Mentioned
- Siemens Healthineers AG
- GE Healthcare Technologies Inc.
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 300 |
Published | June 2025 |
Forecast Period | 2025 - 2034 |
Estimated Market Value ( USD | $ 2.2 Billion |
Forecasted Market Value ( USD | $ 3.48 Billion |
Compound Annual Growth Rate | 4.7% |
Regions Covered | North America |
No. of Companies Mentioned | 4 |